366 related articles for article (PubMed ID: 24579331)
21. Digital mammography screening: weighing reduced mortality against increased overdiagnosis.
de Gelder R; Fracheboud J; Heijnsdijk EA; den Heeten G; Verbeek AL; Broeders MJ; Draisma G; de Koning HJ
Prev Med; 2011 Sep; 53(3):134-40. PubMed ID: 21718717
[TBL] [Abstract][Full Text] [Related]
22. The National Breast Screening Programme: the first 5,000 women screened in Northern Ireland.
O'Doherty AJ; Crothers JG; Majury CW
Ulster Med J; 1991 Oct; 60(2):150-3. PubMed ID: 1785147
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer incidence after the introduction of mammography screening: what should be expected?
Svendsen AL; Olsen AH; von Euler-Chelpin M; Lynge E
Cancer; 2006 May; 106(9):1883-90. PubMed ID: 16572411
[TBL] [Abstract][Full Text] [Related]
24. Screening for breast cancer in England: past and future.
Advisory Committee on Breast Cancer Screening
J Med Screen; 2006; 13(2):59-61. PubMed ID: 16792825
[TBL] [Abstract][Full Text] [Related]
25. [Is “mobile mammography” a Relevant Method in France?].
Vallée A
Sante Publique; 2016 Nov; 28(5):599-602. PubMed ID: 28155735
[TBL] [Abstract][Full Text] [Related]
26. Evolution of breast cancer screening in countries with intermediate and increasing incidence of breast cancer.
Wu GH; Chen LS; Chang KJ; Hou MF; Chen SC; Liu TJ; Huang CS; Hsu GC; Yu CC; Jeng LL; Chen ST; Chou YH; Wu CY; Shin-Lan K; Chen TH;
J Med Screen; 2006; 13 Suppl 1():S23-7. PubMed ID: 17227638
[TBL] [Abstract][Full Text] [Related]
27. [Breast cancer: epidemiology, risk factors, screening].
Gairard B; Mathelin C; Schaffer P; Brettes JP
Rev Prat; 1998 Jan; 48(1):21-7. PubMed ID: 9781206
[TBL] [Abstract][Full Text] [Related]
28. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey.
Duport N
Rev Epidemiol Sante Publique; 2012 Dec; 60(6):421-30. PubMed ID: 23146369
[TBL] [Abstract][Full Text] [Related]
29. Overdiagnosis in the population-based service screening programme with mammography for women aged 40 to 49 years in Sweden.
Hellquist BN; Duffy SW; Nyström L; Jonsson H
J Med Screen; 2012 Mar; 19(1):14-9. PubMed ID: 22355181
[TBL] [Abstract][Full Text] [Related]
30. [Discrepancies and overdiagnosis in breast cancer organized screening. A "methodology" systematic review].
Gocko X; Leclerq M; Plotton C
Rev Epidemiol Sante Publique; 2018 Nov; 66(6):395-403. PubMed ID: 30316554
[TBL] [Abstract][Full Text] [Related]
31. Controversies regarding mammography, breast self-examination, and clinical breast examination.
Nelson AL
Obstet Gynecol Clin North Am; 2013 Sep; 40(3):413-27. PubMed ID: 24021250
[TBL] [Abstract][Full Text] [Related]
32. The balance sheet of benefits and harms of breast cancer population-based screening in Europe: outcome research, practice and future challenges.
Broeders M; Paci E
Womens Health (Lond); 2015 Nov; 11(6):883-90. PubMed ID: 26619214
[TBL] [Abstract][Full Text] [Related]
33. Quantifying the benefits and harms of screening mammography.
Welch HG; Passow HJ
JAMA Intern Med; 2014 Mar; 174(3):448-54. PubMed ID: 24380095
[TBL] [Abstract][Full Text] [Related]
34. Position paper: breast cancer screening, diagnosis, and treatment in Denmark.
Christiansen P; Vejborg I; Kroman N; Holten I; Garne JP; Vedsted P; Møller S; Lynge E
Acta Oncol; 2014 Apr; 53(4):433-44. PubMed ID: 24495043
[TBL] [Abstract][Full Text] [Related]
35. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
Séradour B; Allemand H; Weill A; Ricordeau P
Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
[TBL] [Abstract][Full Text] [Related]
36. Breast cancer incidence trends in Norway and estimates of overdiagnosis.
van Luijt PA; Heijnsdijk EA; van Ravesteyn NT; Hofvind S; de Koning HJ
J Med Screen; 2017 Jun; 24(2):83-91. PubMed ID: 27754936
[TBL] [Abstract][Full Text] [Related]
37. Comparison of interval breast cancer rates for two-versus single-view screening mammography: a population-based study.
Seigneurin A; Exbrayat C; Labarère J; Colonna M
Breast; 2009 Oct; 18(5):284-8. PubMed ID: 19713113
[TBL] [Abstract][Full Text] [Related]
38. Mammographic screening for breast cancer. Overdiagnosis: an insidious adverse effect of screening.
Prescrire Int; 2015 Jul; 24(162):186-9, 191. PubMed ID: 26240891
[TBL] [Abstract][Full Text] [Related]
39. Mammography screening reduces rates of advanced and fatal breast cancers: Results in 549,091 women.
Duffy SW; Tabár L; Yen AM; Dean PB; Smith RA; Jonsson H; Törnberg S; Chen SL; Chiu SY; Fann JC; Ku MM; Wu WY; Hsu CY; Chen YC; Svane G; Azavedo E; Grundström H; Sundén P; Leifland K; Frodis E; Ramos J; Epstein B; Åkerlund A; Sundbom A; Bordás P; Wallin H; Starck L; Björkgren A; Carlson S; Fredriksson I; Ahlgren J; Öhman D; Holmberg L; Chen TH
Cancer; 2020 Jul; 126(13):2971-2979. PubMed ID: 32390151
[TBL] [Abstract][Full Text] [Related]
40. [Breast cancer screening: a better anamnesis and an informed choice].
Fauquert B
Rev Med Brux; 2015 Sep; 36(4):248-54. PubMed ID: 26591308
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
